Health Economics Course 2023
For a decade the EHC has been providing NMOs and a wider community with education on the evolution of health economics, tender process, and procurement in bleeding disorders.
From the first face-to-face meeting in London in 2013, health technology assessments (HTA) have become commonplace in national healthcare systems and bleeding disorders. The ability for an individual patient to input into horizon scanning, model inputs and design, procurement methods, and reporting is increasing with HTA agencies improving their engagement processes. The EHC aims to ensure access to education for patients and patient organisations on-demand for engaging in health technology assessments. As a result, the EHC has decided to create an online educational course on Health Economics in Europe. The program may also act as a quick reference guide for students, researchers, and HTA agencies to begin to understand the issues related to bleeding disorders and how to evaluate them.
The program will be online, consisting of sequential webinars (for self-education) with additional interactive materials to improve personal and NMO knowledge. The course would also provide two Q&A sessions with prominent experts to guide involvement in HTA at any level.
Register here till November 28, 2023. Please note that only registered users will have access to the course materials and will be able to access the Q&A sessions.
Dates of the course:
Launch and 1st module – Dec 4, 2023
2nd module – Dec 6, 2023
1st Q&A session – live – Dec 7, 2023
3rd module – Dec 11, 2023
4th module – Dec 13, 2023
2nd Q&A session – live – Dec 14, 2023
For any questions please contact us at education@ehc.eu.
Jim is aged 66 and has Haemophilia A with a high titer inhibitor which he developed at age 14.
Maria Elisa Mancuso (MD, PhD) is a Haematologist and works as a Senior Haematology Consultant at the Center for Thrombosis and Haemorrhagic Diseases of IRCCS Humanitas Research Hospital in Rozzano, Milan, Italy. She is Adjunct Clinical Professor at Humanitas University. She obtained a post-degree in Clinical and Experimental Haematology and a PhD in Clinical Methodology. She is involved in clinical research and has published several original articles in peer-reviewed journals a The Lancet, Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology and Haemophilia. She is reviewer for several peer-reviewed journals and member of the Editorial Board of JTH. She is a member of several scientific societies (ISTH, WFH, ASH, EAHAD, SISET, AICE) and was a medical member of the Inhibitor Working Group of the European Hemophilia Consortium. She is co-chair of the ADVANCE Study Group. She has acted also as co-chair of the Scientific and Standardization Subcommittee of ISTH on FVIII, FIX and rare bleeding disorders. She has been involved as principal and co-investigator in several clinical trials, and she takes care of both children and adults with hemophilia and other congenital bleeding disorders with a specific scientific interest in novel therapies, prophylaxis, inhibitors, and chronic hepatitis C.
As a patient with factor II deficiency, the diagnostic and treatment of rare bleeding disorders is a matter dear to my heart. My motivation to participate in the work of the ERIN committee is to improve both diagnostic and treatment for patients with rare bleeding disorders across Europe.
Economist and financial expert by profession, executive coach and trainer by passion and haemophilia advocate by every drop of my blood through my son (who has severe haemophilia A with inhibitors). Bringing a good decade of practical experience from the corporate insurance world, laser focus, growth mindset and resilience from my own experience, offering you anything I can just do, in hope that together we can make life more fulfilled for those impacted by bleeding disorders.
Amy Owen-Wyard is a Registered Mental Health Nurse. With experience working with children, young people, their families and adults with severe and enduring mental health conditions. Amy was also involved in a service improvement to provide a holistic care approach for those in general hospitals to support both their mental and physical health, whilst sharing her expertise and knowledge in mental health with the wider multidisciplinary team.
